103 results
S-1/A
SLNO
Soleno Therapeutics Inc
1 Jul 14
IPO registration (amended)
12:00am
for the diagnosis and treatment of hemolysis. To the extent that the nature and scope of the AAP guidelines are equivocal, please revise your summary … stock on pages 66 and F-28. Please tell us the nature
Anish Bhatnagar
June 30, 2014
Page 4
and extent of your reliance on the third party
CORRESP
SLNO
Soleno Therapeutics Inc
17 Sep 14
Correspondence with SEC
12:00am
the nature of the obligation of the underwriter(s) obligation to take the securities.” The Instruction to Paragraph 508(a) provides that “[a]ll … that is required as to the nature of the underwriters’ obligation is whether the underwriters are or will be committed to take and pay for all of the securities
424B3
SLNO
Soleno Therapeutics Inc
14 Oct 15
Prospectus supplement
12:00am
, or any other order of any nature enacted, issued, promulgated, enforced or entered by any Governmental Authority.
“Party” or “Parties” has … “Acquired Assets” means the following assets and properties (together with all goodwill, rights and claims of the Seller of whatever kind and nature
424B3
SLNO
Soleno Therapeutics Inc
14 Oct 15
Prospectus supplement
12:00am
other order of any nature enacted, issued, promulgated, enforced or entered by any Governmental Authority.
“Party” or “Parties” has the meaning set … Assets” means the following assets and properties (together with all goodwill, rights and claims of the Seller of whatever kind and nature relating
D
SLNO
Soleno Therapeutics Inc
24 Feb 10
$4.7M in debt / options / securities to be acquired, sold $3.1M, 12 investors
12:00am
, if the securities that are the subject of this Form D are "covered securities" for purposes of NSMIA, whether in all instances or due to the nature
424B3
nejiz5v ho
24 Jul 17
Prospectus supplement
12:00am
D
bglc6fjsrz9a0f
4 Oct 23
$59.99 mm in equity / options / securities to be acquired, sold $59.99 mm, 14 investors
10:36am
8-K
xnzh4r6 42dq11
27 Jul 15
Capnia Announces $10 Million At-the-Market Firm Commitment Stock Purchase Agreement with Aspire Capital
12:00am
D
16r6e7xx
25 Jan 12
$2M in debt / options / securities to be acquired, sold $1.89M, 17 investors
12:00am
D/A
menevbj0xeenn70
13 Aug 12
$5.19M in debt / options / securities to be acquired, sold $5.02M, 17 investors
12:00am
D/A
5ybum sc5
19 Mar 10
$4.7M in debt / options / securities to be acquired, sold $3.31M, 28 investors
12:00am
8-K
EX-1.1
86zhb7q29 xxdjxg
25 Oct 19
Soleno Therapeutics Announces Pricing of $13.4 Million Public Offering of Common Stock
4:03pm
8-K
EX-1.2
jggclr
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm